Evidence map›Paper›PMID 27256766›Full record

ArticleGenetic epidemiology2016

G-STRATEGY: Optimal Selection of Individuals for Sequencing in Genetic Association Studies.

Miaoyan Wang, Johanna Jakobsdottir, Albert V Smith, Mary Sara McPeek

Abstract read
In one paragraph

Article in Genetic epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Miaoyan WangDepartment of Statistics, University of Chicago, Chicago, Illinois, United States of America.
Johanna JakobsdottirIcelandic Heart Association, Kopavogur, Iceland.
Albert V SmithIcelandic Heart Association, Kopavogur, Iceland.
Mary Sara McPeekDepartment of Statistics, University of Chicago, Chicago, Illinois, United States of America.

Funding

Methods for Human Genetic MappingR01HG001645 · NHGRI · UNIVERSITY OF CHICAGO · PI MCPEEK, MARY SARA · 2003 to 2023
$6.8M
NHGRI NIH HHS R01 HG001645
6 · The paper itself

Abstract

In a large-scale genetic association study, the number of phenotyped individuals available for sequencing may, in some cases, be greater than the study's sequencing budget will allow. In that case, it can be important to prioritize individuals for sequencing in a way that optimizes power for association with the trait. Suppose a cohort of phenotyped individuals is available, with some subset of them possibly already sequenced, and one wants to choose an additional fixed-size subset of individuals to sequence in such a way that the power to detect association is maximized. When the phenotyped sample includes related individuals, power for association can be gained by including partial information, such as phenotype data of ungenotyped relatives, in the analysis, and this should be taken into account when assessing whom to sequence. We propose G-STRATEGY, which uses simulated annealing to choose a subset of individuals for sequencing that maximizes the expected power for association. In simulations, G-STRATEGY performs extremely well for a range of complex disease models and outperforms other strategies with, in many cases, relative power increases of 20-40% over the next best strategy, while maintaining correct type 1 error. G-STRATEGY is computationally feasible even for large datasets and complex pedigrees. We apply G-STRATEGY to data on high-density lipoprotein and low-density lipoprotein from the AGES-Reykjavik and REFINE-Reykjavik studies, in which G-STRATEGY is able to closely approximate the power of sequencing the full sample by selecting for sequencing a only small subset of the individuals.

Indexed as

Genetic Association StudiesSoftwareGenotypeHumansPolymorphism, Single NucleotideQuantitative Trait Lociassociation mappingfamily dataselective genotypingsequencesimulated annealing

Identifiers

PMID27256766
PMCPMC5473612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.